Inactive Instrument
Tobira Therapeutics Inc Stock
Stocks
US88883P1012
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | - |
Scott Reents
DFI | Director of Finance/CFO | 59 | - |
| Corporate Secretary | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.79% | -6.16% | +49.32% | +74.50% | 66.34B | |
| +0.10% | +6.76% | +11.93% | +90.78% | 52.92B | |
| -0.46% | +4.15% | +6.76% | +72.37% | 54.82B | |
| +0.74% | +2.75% | +26.31% | +45.29% | 44.09B | |
| +3.87% | +10.15% | +20.69% | +132.73% | 43.72B | |
| +7.91% | +4.30% | +263.91% | +602.72% | 42.13B | |
| -0.40% | +9.85% | +17.04% | +59.17% | 33.96B | |
| -1.30% | -0.68% | +37.15% | +7.04% | 26.17B | |
| +0.33% | +5.20% | +36.08% | +25.90% | 23.37B | |
| Average | +1.29% | +1.67% | +52.13% | +123.39% | 43.06B | |
| Weighted average by Cap. | +1.37% | +1.99% | +51.22% | +128.26% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
